DK116658B - Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. - Google Patents
Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener.Info
- Publication number
- DK116658B DK116658B DK572664AA DK572664A DK116658B DK 116658 B DK116658 B DK 116658B DK 572664A A DK572664A A DK 572664AA DK 572664 A DK572664 A DK 572664A DK 116658 B DK116658 B DK 116658B
- Authority
- DK
- Denmark
- Prior art keywords
- estrenes
- methyl
- preparation
- therapeutically active
- therapeutically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL300774 | 1963-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK116658B true DK116658B (da) | 1970-02-02 |
Family
ID=19755228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK572664AA DK116658B (da) | 1963-11-20 | 1964-11-20 | Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3383393A (de) |
| BR (1) | BR6464588D0 (de) |
| CH (1) | CH479570A (de) |
| DE (1) | DE1468423A1 (de) |
| DK (1) | DK116658B (de) |
| GB (2) | GB1089915A (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3476783A (en) * | 1965-10-08 | 1969-11-04 | Smithkline Corp | 6,6-ethylene-9alpha-fluoro steroids |
| US3673225A (en) * | 1970-01-16 | 1972-06-27 | Organon | New 7-alkyl-steroids |
| US4038297A (en) * | 1973-05-17 | 1977-07-26 | Emery Industries, Inc. | High molecular weight monocarboxylic acids and ozonization process for their preparation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3262949A (en) * | 1956-11-13 | 1966-07-26 | Syntex Corp | 7-methyl androstane compounds |
| US3312720A (en) * | 1961-03-29 | 1967-04-04 | Organon | 3-desoxy-19-nor-androstenes |
-
1964
- 1964-11-13 US US411109A patent/US3383393A/en not_active Expired - Lifetime
- 1964-11-18 CH CH1484964A patent/CH479570A/de not_active IP Right Cessation
- 1964-11-20 BR BR164588/64A patent/BR6464588D0/pt unknown
- 1964-11-20 DK DK572664AA patent/DK116658B/da unknown
- 1964-11-20 DE DE19641468423 patent/DE1468423A1/de active Pending
- 1964-11-20 GB GB47384/64A patent/GB1089915A/en not_active Expired
- 1964-11-20 GB GB16698/67A patent/GB1089916A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3383393A (en) | 1968-05-14 |
| GB1089916A (en) | 1967-11-08 |
| BR6464588D0 (pt) | 1973-08-02 |
| DE1468423A1 (de) | 1969-01-09 |
| GB1089915A (en) | 1967-11-08 |
| CH479570A (de) | 1969-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK128318B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive bischromoner. | |
| DK116205B (da) | Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ<1,4>-pregnadien-3,20-dioner. | |
| DK108500C (da) | Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner. | |
| DK111956B (da) | Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ<9>-estren. | |
| DK111113B (da) | Fremgangsmåde til fremstilling af 3-methylflavon-8-carboxylsyre. | |
| DK115400B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner. | |
| DK112736B (da) | Fremgangsmåde til fremstilling af N-(3-aminopyrazinoyl)-benzamidiner. | |
| DK111889B (da) | Fremgangsmåde til fremstilling af 3-N-substituerede tricycloundecaner. | |
| DK121708B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater. | |
| DK117635B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler. | |
| DK120596B (da) | Fremgangsmåde til fremstilling af acetoxymethylbenzylpenicillinat. | |
| DK118825B (da) | Fremgangsmåde til fremstilling af adrenocorticotropt virksomme tricosa- eller tetracosapeptider. | |
| DK119107B (da) | Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener. | |
| DK117632B (da) | Fremgangsmåde til fremstilling af 3-alkyliden-Δ<4>-estrener. | |
| DK104461C (da) | Fremgangsmåde til fremstilling af 3-amino-isoxazoler. | |
| DK116658B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. | |
| DK107031C (da) | Fremgangsmåde til fremstilling af 2-halogenmethyl-quinazolin-3-oxider. | |
| DK112235B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ<4>-pregnen-17α-ol-3,20-dioner. | |
| DK104571C (da) | Fremgangsmåde til fremstilling af trans-2-phenyl-3-methylmorpholin. | |
| DK115327B (da) | Fremgangsmåde til fremstilling af hydroxyphenylalkylphosphonater. | |
| DK117488C (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner. | |
| DK121510B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5(10)>-østrener. | |
| DK113991B (da) | Fremgangsmåde til fremstilling af 2-chlor-3-oxo-butanamider. | |
| FI43994C (fi) | Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi | |
| DK109264C (da) | Fremgangsmåde til fremstilling af 1-substituerede-2-cyan-5-nitroimidazoler. |